Health Canada Continues to Support Psychedelic Medicine News May 24, 2022 Health Canada Continues to Support Psychedelic Medicine Albert Labs Love0
Burnaby company granted Health Canada licence to produce ‘magic mushroom medicine’ News May 20, 2022 Burnaby company granted Health Canada licence to produce ‘magic mushroom medicine’ Albert Labs Love0
The Mission to Make Psilocybin Available to UK Cancer Patients News April 25, 2022 The Mission to Make Psilocybin Available to UK Cancer Patients Albert Labs Love0
Is the UK Becoming a Global Center for Psychedelic Medicine? News March 15, 2022 Is the UK Becoming a Global Center for Psychedelic Medicine? Albert Labs Love0
Using Real-World Evidence to Accelerate Psychedelic Drug Development News February 9, 2022 Using Real-World Evidence to Accelerate Psychedelic Drug Development Albert Labs 0 Love0
Albert Labs receives conditional approval for CSE listing News November 30, 2021 Albert Labs receives conditional approval for CSE listing Albert Labs 0 Love0
Another Psychedelics Company Goes Public: Albert Labs To List On CSE, Appoints Chrystal Capital As UK Banker News November 29, 2021 Another Psychedelics Company Goes Public: Albert Labs To List On CSE, Appoints Chrystal Capital As UK Banker Albert Labs 0 Love0
ViewPoints Interview: Albert Labs’ Dr. Malcolm Barratt-Johnson Shares Insights on Psychedelic-Assisted Therapies News June 19, 2021 ViewPoints Interview: Albert Labs’ Dr. Malcolm Barratt-Johnson Shares Insights on Psychedelic-Assisted Therapies Albert Labs 0 Love0
Drug developer uses RWE to research psychedelic therapies News June 19, 2021 Drug developer uses RWE to research psychedelic therapies Albert Labs 0 Love0
Albert Labs announces C$4M financing ahead of CSE listing News April 15, 2021 Albert Labs announces C$4M financing ahead of CSE listing Albert Labs 0 Love0
